M Y Feng 1 , J H Zhuang 1 , H H Gu 1 , Q Tian 1 , Z H Zhang 1 . Show Affiliations »
Abstract
Objective:To investigate the changes of serum estradiol(E2) and otolith structural protein Otolin-1 levels in postmenopausal women with benign paroxysmal positional vertigo(BPPV). Method:Forty postmenopausal women diagnosed as primary BPPV were selected as the experimental group. Meanwhile, 40 postmenopausal women without vertigo during the same time were selected as the control group. 4 ml of fasting peripheral venous blood was extracted in the morning, and E2 and Otolin-1 protein levels in serum of the two groups were detected by electrochemiluminescence(ECL) and ELISA, respectively. Result:①The serum level of E2 in the experimental group was(29.11±15.11) pg/ml, which was lower than that in the control group(37.18±12.24) pg/ml(P=0.010). ②The serum level of Otolin-1 in the experimental group was(361.55±186.14) pg/ml, which was significantly higher than that in the control group(282.61±139.98) pg/ml(P=0.035). ③Spearman correlation analysis was carried out on the serum levels of Otolin-1 and E2 in the experimental group and the control group, respectively, and no correlation was found between them(P=0.403 and 0.363, respectively). ④In the control group, age was negatively correlated with serum E2 level(P=0.044, r=-0.320), suggesting that age was only weakly correlated with E2 level. However, in the experimental group, there was no correlation between the two(P=0.148). ⑤There was no correlation between age and serum Otolin-1 level in the two groups(P=0.705 and 0.076, respectively). Conclusion: Compared with postmenopausal patients without vertigo, the level of E2 in postmenopausal BPPV patients decreased, but the level of Otolin-1 increased significantly. Therefore, the serum level of Otolin-1 may be used as a bio-marker to assist the diagnosis and efficacy evaluation of postmenopausal women with BPPV. Copyright© by the Editorial Department of Journal of Clinical Otorhinolaryngology Head and Neck Surgery.
Objective:To investigate the changes of serum estradiol (E2) and otolith structural protein Otolin-1 levels in postmenopausal women with benign paroxysmal positional vertigo (BPPV). Method:Forty postmenopausal women diagnosed as primary BPPV were selected as the experimental group. Meanwhile, 40 postmenopausal women without vertigo during the same time were selected as the control group. 4 ml of fasting peripheral venous blood was extracted in the morning, and E2 and Otolin-1 protein levels in serum of the two groups were detected by electrochemiluminescence(ECL) and ELISA, respectively. Result:①The serum level of E2 in the experimental group was(29.11±15.11) pg/ml, which was lower than that in the control group(37.18±12.24) pg/ml(P=0.010). ②The serum level of Otolin-1 in the experimental group was(361.55±186.14) pg/ml, which was significantly higher than that in the control group(282.61±139.98) pg/ml(P=0.035). ③Spearman correlation analysis was carried out on the serum levels of Otolin-1 and E2 in the experimental group and the control group, respectively, and no correlation was found between them(P=0.403 and 0.363, respectively). ④In the control group, age was negatively correlated with serum E2 level(P=0.044, r=-0.320), suggesting that age was only weakly correlated with E2 level. However, in the experimental group, there was no correlation between the two(P=0.148). ⑤There was no correlation between age and serum Otolin-1 level in the two groups(P=0.705 and 0.076, respectively). Conclusion: Compared with postmenopausal patients without vertigo , the level of E2 in postmenopausal BPPV patients decreased, but the level of Otolin-1 increased significantly. Therefore, the serum level of Otolin-1 may be used as a bio-marker to assist the diagnosis and efficacy evaluation of postmenopausal women with BPPV. Copyright© by the Editorial Department of Journal of Clinical Otorhinolaryngology Head and Neck Surgery.
Entities: Chemical
Disease
Gene
Species
Keywords:
Otolin-1; bio-marker; estradiol; postmenopausal women; vertigo
Mesh: See more »
Substances: See more »
Year: 2019
PMID: 31914260 DOI: 10.13201/j.issn.1001-1781.2019.12.006
Source DB: PubMed Journal: Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi ISSN: 1001-1781